Ketone bodies and incident heart failure: 20-year results from the prospective British Regional Heart Study

酮体与心力衰竭发生率:英国区域心脏研究前瞻性研究的20年结果

阅读:1

Abstract

INTRODUCTION: Ketone bodies (KBs), acetoacetate, and β-hydroxybutyrate, are an important fat-derived alternative energy source for the heart and have been implicated in the pathogenesis of cardiovascular disease. The study aimed to determine the relationship between total KB (acetoacetate + β-hydroxybutyrate) and KB ratio (acetoacetate:β-hydroxybutyrate) with incident heart failure (HF) in older men. METHODS: Three thousand four hundred fifty-nine men without prevalent myocardial infarction or HF from the prospective cohort British Regional Heart Study were included in the analysis. Ketone body levels were measured by nuclear magnetic resonance spectroscopy. Participants were followed up for a median 15.9 years. RESULTS: Three hundred seventy-five men developed HF. Total KB was not significantly associated with incident HF {age-adjusted standardized hazard ratios [HRs] [95% confidence interval (CI)] 0.94 [0.84-1.04], P = .231 for trend}. However, KB ratio was significantly associated with incident HF (age-adjusted standardized HR (95% CI) 1.12 [1.01-1.24], P = .023 for trend). Risk tended to increase with increasing levels of KB ratio from 0.35 with risk significantly raised when the KB ratio was above 0.55 (top decile) even after adjustment for traditional cardiovascular risk factors, inflammatory markers, and NT-pro-BNP [HR (95% CI) for KB ratio >0.55 vs <0.18 (bottom quartile) = 1.60 (1.13-2.27), P = .008]. The increased risk associated with elevated KB ratio was more evident in the younger men (age <70 years). When examined by levels of NT-pro-BNP, elevated KB ratio was significantly associated with increased HF risk only in the presence of elevated NT-pro-BNP (>83 pg/ml; above the median) [age-adjusted HR = 1.87 (1.25-2.81)]. Weaker associations were seen in those without raised NT-pro-BNP [HR = 1.23 (0.66-2.27)]. CONCLUSION: Elevated KB ratio is associated with a significantly increased risk of HF and may serve as a biomarker of HF incidence particularly when NT-pro-BNP is also elevated.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。